Biomarkers of AKI in Patients Receiving Daratumumab

NCT06549634 · clinicaltrials.gov ↗

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Acute Kidney Injury
Multiple Myeloma
Light Chain Nephropathy

Interventions

DRUG: Daratumumab

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]